Evidence map›Paper›PMID 42403843›Full record

ArticleCureus2026

Pulmonary Vein Stenosis Following Ablation for Atrial Fibrillation.

Gráinne O'Brien, Adel Tachouli, Eirini Kasfiki

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gráinne O'BrienAcute Medicine, Hull University Teaching Hospitals NHS Trust, Hull, GBR.
Adel TachouliAcute Medicine, Hull University Teaching Hospitals NHS Trust, Hull, GBR.
Eirini KasfikiAcute Medicine, Hull University Teaching Hospitals NHS Trust, Hull, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary vein stenosis (PVS) is a rare but potentially serious complication of catheter ablation for atrial fibrillation (AF), often presenting with non-specific respiratory symptoms and initially misdiagnosed. Early recognition is crucial to reduce the risks of progressive pulmonary hypertension, infarction, and long-term morbidity. We report a 65-year-old woman who presented with progressive dyspnoea on exertion, marked reduced exercise tolerance, lethargy, chest pain , and new onset haemoptysis. These symptoms began five months following an ablation procedure for symptomatic AF. Initial evaluations by primary care and cardiology teams attributed symptoms to lower respiratory tract infection or drug toxicity. On admission to the hospital, vital signs were normal, and routine investigations were unremarkable. Cardiac CT with pulmonary venography confirmed high-grade ostial stenosis (> 90%) of both left pulmonary veins. The patient underwent elective percutaneous pulmonary venoplasty with stenting under general anaesthesia. Post-procedural follow-up showed marked improvement in symptoms and patency of the left pulmonary veins on imaging. PVS secondary to catheter ablation is a rare but important post-ablation complication, which is frequently misdiagnosed due to non-specific symptoms. High clinical suspicion, early imaging, and timely endovascular intervention are important to optimise outcomes and minimise restenosis risk. Clinicians should consider PVS in any patient presenting with progressive dyspnoea, haemoptysis , or chest pain in the months following atrial ablation. This case highlights the importance of awareness to enable early diagnosis and treatment, preventing potential morbidity.

Indexed as

atrial fibrillationcatheter ablationdyspnoeahaemoptysispulmonary vein stenosis

Identifiers

PMID42403843
PMCPMC13329136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.